BACE1 and Alzheimer disease: BACE1-AS expression levels decreased in the pre-AD subgroup's Plasma and increased in AD patients' Plasma relative to controls. Roc curve analysis can differentiate between pre-AD patients and healthy controls with a sensitivity of 75%, between full-AD patients and healthy controls with a sensitivity of 68%, and between pre-AD and full-AD patients with a sensitivity of 78%.